In women, is the incidence of cervical dysplasia and neoplasia decreased in those who receive the HPV vaccination compared to those who do not .

Human papillomavirus (HPV) is a double-stranded DNA virus with carcinogenic properties directly linked with cervical abnormalities and cancer. It is the most common sexually transmitted disease in the United States. There are many different strains of HPV. The most virulent strains linked to the majority of cervical dysplasia include HPV 16, 18, 31, 33, 45, 52, and 58.22
Purpose: The purpose of this analysis is to evaluate the efficacy of the HPV vaccination in preventing cervical dysplasia and neoplasia in women compared to those who do not receive the vaccination.

Materials and Methods: Research was conducted using the following: PubMed, Google Scholar, and Ovid. Keywords searched were “HPV”, “women”, “vaccination”, and “cervical dysplasia”. Inclusion criteria included females who received the HPV vaccination. Exclusion criteria included no reviews or meta-analysis and no paper over 10 years old. Twenty-six articles met the set parameters.


Sierra Olson

Abstract | PDF

Share this  Facebook  Twitter  LinkedIn  Google+
Awards Nomination 17+ Million Readerbase
Google scholar citation report
Citations : 49

Journal of Reproductive Health and Contraception received 49 citations as per google scholar report

Journal of Reproductive Health and Contraception peer review process verified at publons
Abstracted/Indexed in
  • Google Scholar
  • China National Knowledge Infrastructure (CNKI)
  • WorldCat
  • Publons

View More »

Flyer image